Xu, Xin

Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells

Goya, K., Sumitani, S., Xu, X., Kitamura, T., Yamamoto, H., Kurebayashi, S., Saito, H., Kouhara, H., Kasayama, S., & Kawase, I. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology

Peroxisome Proliferator-Activated ReceptorsNitric Oxide and Endothelin Effects

Cited by 174

The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells

Goya, K., Sumitani, S., Otsuki, M., Xu, X., Yamamoto, H., Kurebayashi, S., Saito, H., Kouhara, H., & Kasayama, S. (2006) · Journal of Diabetes and its Complications

Nitric Oxide and Endothelin EffectsPeroxisome Proliferator-Activated Receptors

Cited by 43

High ATF4 expression is associated with poor prognosis, amino acid metabolism, and autophagy in gastric cancer

Wang, M., Lu, Y., Wang, H., Wu, Y., Xu, X., & Li, Y. (2021) · Frontiers in Oncology

Gastric Cancer Management and OutcomesAutophagy in Disease and Therapy

Cited by 36

Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution

Xu, X., Cui, L., Zhang, Y., & Gu, J. (2026) · Acta Pharmaceutica Sinica B

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 13